化合物JAK-IN-11 T12549
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 916742-11-5 | ¥26,800.00 | 询底价 |
1 mg | 916742-11-5 | ¥4,990.00 | 询底价 |
100 mg | 916742-11-5 | ¥36,300.00 | 询底价 |
10 mg | 916742-11-5 | ¥13,300.00 | 询底价 |
1 mL | 916742-11-5 | ¥10,800.00 | 询底价 |
5 mg | 916742-11-5 | ¥9,990.00 | 询底价 |
25 mg | 916742-11-5 | ¥19,600.00 | 询底价 |
Product Introduction
Bioactivity
英文名: JAK-IN-11
描述: JAK-IN-11 (R-348)是 JAK 的强效选择性抑制剂,具有治疗皮肤疾病的潜力。
体外活性: JAK/STAT signaling has been implicated in the mediation of many abnormal immune responses such as allergies, asthma, autoimmune diseases such as transplant rejection, rheumatoid arthritis, amyotrophic lateral sclerosis and multiple sclerosis, ocular disorders and diseases, as well as in solid and hematologic malignancies such as leukemia and lymphomas[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (103.41 mM)
关键字: R348 | R 348 | JAK-IN-11
相关产品: BD750 | JAK-IN-30 | JANEX-1 | Deucravacitinib | JAK2-IN-4 | TAK-659 hydrochloride | Peficitinib | Avitinib | Povorcitinib phosphate | (E/Z)-Zotiraciclib
相关库: ReFRAME Related Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Anti-Lung Cancer Compound Library | Inhibitor Library | Kinase Inhibitor Library | Epigenetics Compound Library | Anti-Pancreatic Cancer Compound Library | Bioactive Compound Library
化合物JAK-IN-11 T12549信息由TargetMol中国为您提供,如您想了解更多关于化合物JAK-IN-11 T12549报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途